Jessica L. Flesher

Dr. Jessica L. Flesher

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2022 in JCI Insight
Verified
Journal Article
Open access
PDF file
JSJessica Shiu
Jessica Shiu
LZLihua Zhang
Lihua Zhang
GLGriffin Lentsch
Griffin Lentsch
JFJessica L. Flesher
Jessica L. Flesher
SJSuoqin Jin
Suoqin Jin
AGAnand K. Ganesan
Anand K. Ganesan
Vitiligo is an autoimmune skin disease characterized by the destruction of melanocytes by autoreactive CD8 + T cells. Melanocyte destruction in active vitiligo is mediated by CD8 + T cells, but the persistence of white patches in stable disease is poorly understood. The interaction between immune cells, melanocytes, and keratinocytes in situ in human skin has been difficult to study due to the lack of proper tools. We combine noninvasive multiphoton microscopy (MPM) imaging and single-cell RNA-Seq (scRNA-Seq) to identify subpopulations of keratinocytes in stable vitiligo patients. We show that, compared with nonlesional skin, some keratinocyte subpopulations are enriched in lesional vitiligo skin and shift their energy utilization toward oxidative phosphorylation. Systematic investigation of cell-to-cell communication networks show that this small population of keratinocyte secrete CXCL9 and CXCL10 to potentially drive vitiligo persistence. Pseudotemporal dynamics analyses predict an alternative differentiation trajectory that generates this new population of keratinocytes in vitiligo skin. Further MPM imaging of patients undergoing punch grafting treatment showed that keratinocytes favoring oxidative phosphorylation persist in nonresponders but normalize in responders. In summary, we couple advanced imaging with transcriptomics and bioinformatics to discover cell-to-cell communication networks and keratinocyte cell states that can perpetuate inflammation and prevent repigmentation.

21 June 2023 in Nature
Verified
Journal Article
Open access
PDF file
XWXiaojie Wang
Xiaojie Wang
RRRaul Ramos
Raul Ramos
APAnne Q. Phan
Anne Q. Phan
KYKosuke Yamaga
Kosuke Yamaga
JFJessica L. Flesher
Jessica L. Flesher
MPMaksim V. Plikus
Maksim V. Plikus
Niche signals maintain stem cells in a prolonged quiescence or transiently activate them for proper regeneration1. Altering balanced niche signalling can lead to regenerative disorders. Melanocytic skin nevi in human often display excessive hair growth, suggesting hair stem cell hyperactivity. Here, using genetic mouse models of nevi2,3, we show that dermal clusters of senescent melanocytes drive epithelial hair stem cells to exit quiescence and change their transcriptome and composition, potently enhancing hair renewal. Nevus melanocytes activate a distinct secretome, enriched for signalling factors. Osteopontin, the leading nevus signalling factor, is both necessary and sufficient to induce hair growth. Injection of osteopontin or its genetic overexpression is sufficient to induce robust hair growth in mice, whereas germline and conditional deletions of either osteopontin or CD44, its cognate receptor on epithelial hair cells, rescue enhanced hair growth induced by dermal nevus melanocytes. Osteopontin is overexpressed in human hairy nevi, and it stimulates new growth of human hair follicles. Although broad accumulation of senescent cells, such as upon ageing or genotoxic stress, is detrimental for the regenerative capacity of tissue4, we show that signalling by senescent cell clusters can potently enhance the activity of adjacent intact stem cells and stimulate tissue renewal. This finding identifies senescent cells and their secretome as an attractive therapeutic target in regenerative disorders.

19 August 2020 in Communications Biology
Verified
Journal Article
Open access
PDF file
AHAmber N Habowski
Amber N Habowski
JFJessica L. Flesher
Jessica L. Flesher
JBJennifer M. Bates
Jennifer M. Bates
CTChia-Feng Tsai
Chia-Feng Tsai
KMKendall Martin
Kendall Martin
MWMarian L. Waterman
Marian L. Waterman
Intestinal stem cells are non-quiescent, dividing epithelial cells that rapidly differentiate into progenitor cells of the absorptive and secretory cell lineages. The kinetics of this process is rapid such that the epithelium is replaced weekly. To determine how the transcriptome and proteome keep pace with rapid differentiation, we developed a new cell sorting method to purify mouse colon epithelial cells. Here we show that alternative mRNA splicing and polyadenylation dominate changes in the transcriptome as stem cells differentiate into progenitors. In contrast, as progenitors differentiate into mature cell types, changes in mRNA levels dominate the transcriptome. RNA processing targets regulators of cell cycle, RNA, cell adhesion, SUMOylation, and Wnt and Notch signaling. Additionally, global proteome profiling detected >2,800 proteins and revealed RNA:protein patterns of abundance and correlation. Paired together, these data highlight new potentials for autocrine and feedback regulation and provide new insights into cell state transitions in the crypt.

27 March 2018 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
MLMarc C Liggins
Marc C Liggins
JFJessica L. Flesher
Jessica L. Flesher
SJSohail Jahid
Sohail Jahid
PVPriya Vasudeva
Priya Vasudeva
VEVictoria Eby
Victoria Eby
AGAnand K Ganesan
Anand K Ganesan
PIKfyve, VAC14, and FIG4 form a complex that catalyzes the production of PI(3,5)P2, a signaling lipid implicated in process ranging from lysosome maturation to neurodegeneration. While previous studies have identified VAC14 and FIG4 mutations that lead to both neurodegeneration and coat color defects, how PIKfyve regulates melanogenesis is unknown. In this study, we sought to better understand the role of PIKfyve in melanosome biogenesis. Melanocyte-specific PIKfyve knockout mice exhibit greying of the mouse coat and the accumulation of single membrane vesicle structures in melanocytes resembling multivesicular endosomes. PIKfyve inhibition blocks melanosome maturation, the processing of the melanosome protein PMEL, and the trafficking of the melanosome protein TYRP1. Taken together, these studies identify a novel role for PIKfyve in controlling the delivery of proteins from the endosomal compartment to the melanosome, a role that is distinct from the role of PIKfyve in the reformation of lysosomes from endolysosomes. In order for a cell to develop and maintain functional organelles, proteins must be delivered to developing organelles in a precise, sequential fashion. In this study, we used a well-established model for organelle biogenesis (the melanosome) to understand how phosphoinositides regulate vesicle trafficking and melanogenesis. Blocking PI(3,5)P2 synthesis inhibits melanosome maturation and induces the accumulation of multivesicular endosomes. Intriguingly, this role is different from the role of PI(3,5)P2 in lysosomal reformation. Taken together, these studies identify distinct roles for PI(3,5)P2 in melanosome biogenesis.

12 October 2021 in Epigenomes
Verified
Journal Article
Open access
PDF file
JFJessica L. Flesher
Jessica L. Flesher
DFDavid E. Fisher
David E. Fisher
Epigenetic regulation is a crucial component of DNA maintenance and cellular identity. As our understanding of the vast array of proteins that contribute to chromatin accessibility has advanced, the role of epigenetic remodelers in disease has become more apparent. G9a is a histone methyltransferase that contributes to immune cell differentiation and function, neuronal development, and has been implicated in diseases, including cancer. In melanoma, recurrent mutations and amplifications of G9a have led to its identification as a therapeutic target. The pathways that are regulated by G9a provide an insight into relevant biomarkers for patient stratification. Future work is aided by the breadth of literature on G9a function during normal differentiation and development, along with similarities to EZH2, another histone methyltransferase that forms a synthetic lethal relationship with members of the SWI/SNF complex in certain cancers. Here, we review the literature on G9a, its role in melanoma, and lessons from EZH2 inhibitor studies.

3 September 2020 in Communications Biology
Verified
Journal Article
Open access
PDF file
AHAmber N Habowski
Amber N Habowski
JFJessica L. Flesher
Jessica L. Flesher
JBJennifer M. Bates
Jennifer M. Bates
CTChia-Feng Tsai
Chia-Feng Tsai
KMKendall Martin
Kendall Martin
MWMarian L. Waterman
Marian L. Waterman
An amendment to this paper has been published and can be accessed via a link at the top of the paper.